Literature DB >> 1825989

Characterization of a glycosyl-phosphatidylinositol-anchored membrane protein from Trypanosoma cruzi.

C Hernández-Munaín1, M A Fernández, A Alcina, M Fresno.   

Abstract

Four monoclonal antibodies (MAbs) specific for Trypanosoma cruzi were obtained. Flow cytometry analysis showed that these four MAbs stained the membranes of the three main morphological forms of T. cruzi: amastigotes, trypomastigotes, and epimastigotes. The four MAbs seemed to recognize the same 50- to 55-kDa antigen that was revealed by immunoblotting. Competition experiments revealed that they defined at least two different epitopes on the molecule. The antigen was detected on the external surface of the membrane by immunoelectron microscopy. Several experiments indicated that the 50- to 55-kDa antigen recognized by these four MAbs was a glycosyl-phosphatidylinositol-anchored membrane protein. (i) The antigen could be removed from the cell surface by treatment with proteases, NaOH, HNO2, and phosphatidylinositol-specific phospholipase C (PI-PLC). (ii) The phase distribution of the antigen in Triton X-114 solutions changed drastically upon treatment with PI-PLC. The antigen was found mainly in the detergent phase in nontreated samples and in the aqueous phase in PI-PLC-digested samples. (iii) A cross-reacting determinant that was found in other glycosyl-phosphatidylinositol-anchored membrane proteins appeared after PI-PLC treatment.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1825989      PMCID: PMC257857          DOI: 10.1128/iai.59.4.1409-1416.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  Circulating antibodies to peripheral nerve in American trypanosomiasis (Chagas' disease).

Authors:  E L Khoury; V Ritacco; P M Cossio; R P Laguens; A Szarfman; C Diez; R M Arana
Journal:  Clin Exp Immunol       Date:  1979-04       Impact factor: 4.330

2.  Protective immunisation of mice using cell surface glycoprotein from Trypanosoma cruzi.

Authors:  M T Scott; D Snary
Journal:  Nature       Date:  1979-11-01       Impact factor: 49.962

Review 3.  Biochemistry of the glycosyl-phosphatidylinositol membrane protein anchors.

Authors:  M G Low
Journal:  Biochem J       Date:  1987-05-15       Impact factor: 3.857

Review 4.  Immunobiology of Trypanosoma cruzi infection and Chagas's disease.

Authors:  L Hudson
Journal:  Trans R Soc Trop Med Hyg       Date:  1981       Impact factor: 2.184

5.  Endogenous and surface labeling of glycoconjugates from the three differentiation stages of Trypanosoma cruzi.

Authors:  B Zingales; N F Martin; R M de Lederkremer; W Colli
Journal:  FEBS Lett       Date:  1982-06-07       Impact factor: 4.124

6.  Chagasic cardiopathy. Antibodies reacting with plasma membrane of striated muscle and endothelial cells.

Authors:  P M Cossio; R P Laguens; C Diez; A Szarfman; A Segal; R M Arana
Journal:  Circulation       Date:  1974-12       Impact factor: 29.690

7.  Suppressor cells present in the spleens of Trypanosoma cruzi-infected mice.

Authors:  C Ramos; I Schädtler-Siwon; L Ortiz-Ortiz
Journal:  J Immunol       Date:  1979-04       Impact factor: 5.422

8.  Glycosyl-sn-1,2-dimyristylphosphatidylinositol is covalently linked to Trypanosoma brucei variant surface glycoprotein.

Authors:  M A Ferguson; M G Low; G A Cross
Journal:  J Biol Chem       Date:  1985-11-25       Impact factor: 5.157

9.  The Thy-1 antigen exhibits rapid lateral diffusion in the plasma membrane of rodent lymphoid cells and fibroblasts.

Authors:  A Ishihara; Y Hou; K Jacobson
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

10.  Cell surface antigens of Trypanosoma cruzi: use of monoclonal antibodies to identify and isolate an epimastigote specific glycoprotein.

Authors:  D Snary; M A Ferguson; M T Scott; A K Allen
Journal:  Mol Biochem Parasitol       Date:  1981-10       Impact factor: 1.759

View more
  6 in total

1.  The major surface glycoprotein of Trypanosoma cruzi amastigotes are ligands of the human serum mannose-binding protein.

Authors:  S J Kahn; M Wleklinski; R A Ezekowitz; D Coder; A Aruffo; A Farr
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  Glycosylphosphatidylinositols are required for the development of Trypanosoma cruzi amastigotes.

Authors:  N Garg; M Postan; K Mensa-Wilmot; R L Tarleton
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

Review 3.  The structure, biosynthesis and function of glycosylated phosphatidylinositols in the parasitic protozoa and higher eukaryotes.

Authors:  M J McConville; M A Ferguson
Journal:  Biochem J       Date:  1993-09-01       Impact factor: 3.857

Review 4.  Chagas' disease.

Authors:  H B Tanowitz; L V Kirchhoff; D Simon; S A Morris; L M Weiss; M Wittner
Journal:  Clin Microbiol Rev       Date:  1992-10       Impact factor: 26.132

5.  A 37-kilodalton glycoprotein of Babesia divergens is a major component of a protective fraction containing low-molecular-mass culture-derived exoantigens.

Authors:  B Carcy; E Precigout; A Valentin; A Gorenflot; J Schrevel
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

6.  A Trypanosoma cruzi membrane protein shares an epitope with a lymphocyte activation antigen and induces crossreactive antibodies.

Authors:  C Hernández-Munaín; J L De Diego; A Alcina; M Fresno
Journal:  J Exp Med       Date:  1992-06-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.